Mohamad Ali Alhajhusain

Mohamad Alhajhusain practices at Omaha West Dialysis in Omaha, Nebraska.

Mohamad Alhajhusain's NPI, 1770713257, was assigned on July 20, 2009. Mohamad Alhajhusain graduated from University of Aleppo Faculty of Medicine in 2006. Mohamad Alhajhusain holds Nebraska license 27333.

Mohamad Alhajhusain's primary practice is Omaha West Dialysis, at 7710 Mercy Rd, Omaha, NE 68124 in Douglas County. The practice phone is (402) 445-8950.

Mohamad Alhajhusain's primary practice is Omaha West Dialysis in Omaha, Nebraska. Mohamad Alhajhusain is also affiliated with CHI Health Creighton University Medical Center - Bergan Mercy. The medical group on file is CHI Health Clinic. Dmand AI also links Mohamad Alhajhusain to 5 more hospitals, 5 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mohamad Alhajhusain practices, 12 sites in all. Vendor and product names are available with a free account.

Nephrology is Mohamad Alhajhusain's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Mohamad Alhajhusain is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Mohamad Alhajhusain's licenses on file in 4 states: Nebraska, Ohio, Iowa and Pennsylvania.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and hypercalcemia among the conditions Mohamad Alhajhusain treats.

CMS data shows 1,451 Medicare services from Mohamad Alhajhusain across 12 procedure codes in 2024, for 538 Medicare patients. Medicare paid $105,688 for them.

CMS counts 538 Medicare patients who saw Mohamad Alhajhusain in 2024. The largest group is 75 to 84, with 205 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 3.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mohamad Alhajhusain's median patient age at 69, with 50% women.

In 2024, Mohamad Alhajhusain wrote 1,745 Medicare Part D claims for 329 patients. 88% of them were for generic drugs. CMS names the drug for 1,525 of them, across 32 drugs with 11 or more claims each, at $92,889 in total drug cost. In 2023, CMS named 1,376 claims across 29 drugs.

Mohamad Alhajhusain accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Mohamad Alhajhusain in 2021. Mohamad Alhajhusain's most frequent co-authors are Sunil Kumar Jagadesh, MD and Sangeeta Mutnuri, MD.

CMS Open Payments shows 56 general payments to Mohamad Alhajhusain from 15 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 86% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $138.

Dmand AI lists 1 award for Mohamad Alhajhusain, most recently CMS Stage 1 EHR in 2013.

Mohamad Alhajhusain graduated from University of Aleppo Faculty of Medicine in 2006.

Mohamad Alhajhusain is in network with 17 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Medica. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.